The long dark winter wasn’t bad for everyone - like-for-like sales of health products rose 13%, with Strepsils, Durex and Nurofen particularly strong, and the company is increasing investment in NPD and marketing as Kapoor, a year after taking over from Bart Becht, repositions RB as a health and hygiene company. The share price has recently been trading at an all-time high.
No comments yet